FundedIQ
Biotechnology

Revyve: Funding, Investors & Team (Sep 2026)

Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include emulsifiers, heat-set gels, and foaming agents. It helps customers with special protein functionality requests.

revyve.bio Wageningen, Netherlands 1-10 employees
Total raised
$37.1M
Rounds
2
Latest
Series B
Sep 2025

Revyve has raised $37.1M across 2 funding rounds on record, the most recent a Series B of $28.3M announced in Sep 2025.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Revyve Company Profile and Key Stats

Total funding raised
$37.1M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series B
$28.3M in Sep 2025
Employees
1-10
reported band
Headquarters
Wageningen, Netherlands

Latest funding round on record: Sep 2025.

Revyve Funding Rounds

Date
Round
Amount
Series B
$28.3M
Undisclosed round
$8.8M

Revyve raised $8.8M in an undisclosed round announced in May 2023.

2.3 years later, a Series B of $28.3M was announced in Sep 2025.

Revyve Founders and Leadership Team

Name
Role
Contact
Corjan Van Den Berg
Founder
Cedric Verstraeten
CEO
Locked

Contact details for the Revyve team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

Revyve Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
740
$5.0M
4,289
$30M

Revyve's latest round of $28.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Revyve in Biotechnology and Wageningen

Companies Similar to Revyve

The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…

Series B $20.5M

Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…

Undisclosed round $45.4M

Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…

Undisclosed round $47.8M

Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…

Undisclosed round

Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…

Undisclosed round $300M

Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…

Series B $60.0M

We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…

Undisclosed round $5.7M

QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.

Pre-Seed $2.4M

Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…

Undisclosed round $1.1M

QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…

Undisclosed round $2.6M

BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…

Seed $3.1M

Citryll is a private pharmaceutical company that develops pharmaceutical drugs used to treat autoimmune and…

Series B $89.9M

Revyve Funding FAQs

What does Revyve do?

Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include emulsifiers, heat-set gels, and foaming agents. It helps customers with special protein functionality requests.

How much funding has Revyve raised?

Revyve has raised $37.1M across 2 rounds on record. The most recent is a Series B of $28.3M announced in Sep 2025.

When did Revyve last raise funding?

Revyve's most recent funding round on record is a Series B of $28.3M, announced in Sep 2025.

Who founded Revyve?

FundedIQ lists Corjan Van Den Berg (Founder) at Revyve.

Who is the CEO of Revyve?

Cedric Verstraeten is listed as CEO at Revyve.

Where is Revyve headquartered?

Revyve is based in Wageningen, Gelderland, Netherlands.

How many employees does Revyve have?

Revyve is in the 1-10 employee band.

How does Revyve's funding compare to other Biotechnology startups?

Revyve's latest round of $28.3M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Revyve Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Revyve is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.